Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid

Kramer N, Müller G, Zierold S, Röckel M, Fröhlich W, Schefzyk M, Kumbrink J, Hassel JC, Berking C, Ziemer M, Nashan D, French LE, Vera González J, Kerl-French KE, Gutzmer R, Heinzerling L (2024)

Publication Language: English

Publication Type: Journal article, Letter

Publication year: 2024

Journal

Journal of the European Academy of Dermatology and Venereology Wiley-Blackwell

DOI: 10.1111/jdv.19860

Authors with CRIS profile

Magdalena Röckel Department of Dermatology Carola Berking Lehrstuhl für Haut- und Geschlechtskrankheiten Julio Vera González Professur für Tumorimmunologie (Schwerpunkt Systembiologie)

Involved external institutions

Universitätsklinikum Heidelberg

Germany (DE) Universitätsklinikum Leipzig

Germany (DE) Klinikum Dortmund

Germany (DE) Klinikum der Universität München

Germany (DE) Johannes Wesling Klinikum Minden

Germany (DE) Medizinische Hochschule Hannover (MHH) / Hannover Medical School

Germany (DE) Ludwig-Maximilians-Universität (LMU)

Germany (DE)

How to cite

APA:

Kramer, N., Müller, G., Zierold, S., Röckel, M., Fröhlich, W., Schefzyk, M.,... Heinzerling, L. (2024). Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.19860

MLA:

Kramer, N., et al. "Checkpoint inhibitor-induced bullous pemphigoid differs from spontaneous bullous pemphigoid." Journal of the European Academy of Dermatology and Venereology (2024).

BibTeX: Download